Adenosine

Adenosine

Form: Intravenous (IV) Injection

Strength: 3 mg/mL

Reference Brands: Adenocard(US); Adenocor(EU)

Category: Critical Care

Adenosine is a fast-acting antiarrhythmic agent used primarily for the acute treatment of paroxysmal supraventricular tachycardia (PSVT). It is administered as a rapid IV bolus and acts by slowing conduction through the AV node. Adenosine is typically available in 3 mg/mL concentration, supplied in 6 mg/2 mL and 12 mg/4 mL vials or pre-filled syringes. US brands include Adenocard and generics by Pfizer and Fresenius. In the EU, Adenocor and Adenosine Stragen are commonly used. As a critical emergency medicine, adenosine is widely procured by hospitals, emergency departments, and ICUs through pharma B2B platforms and institutional tenders.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details Get Enquiry
Insulin (IV)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details Get Enquiry
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.